NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zymeworks Inc. ZYME, Pro-Dex, Inc. PDEX, Cantel Medical Corp. CMD, Vaalco Energy Inc EGY, Perion Network Ltd PERI, and Atlas Financial Holdings, Inc. AFH, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ZYME DOWNLOAD: http://Fundamental-Markets.com/register/?so=ZYME
PDEX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PDEX
CMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=CMD
EGY DOWNLOAD: http://Fundamental-Markets.com/register/?so=EGY
PERI DOWNLOAD: http://Fundamental-Markets.com/register/?so=PERI
AFH DOWNLOAD: http://Fundamental-Markets.com/register/?so=AFH
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Zymeworks Inc. ZYME, Pro-Dex, Inc. PDEX, Cantel Medical Corp. CMD, Vaalco Energy Inc EGY, Perion Network Ltd PERI, and Atlas Financial Holdings, Inc. AFH on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ZYMEWORKS INC. (ZYME) REPORT OVERVIEW
Zymeworks' Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Zymeworks reported revenue of $28.93MM vs $50.07MM (down 42.23%) and analysts estimated basic earnings per share $0.38 vs $1.89 (down 79.89%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Zymeworks reported revenue of $53.02MM vs $51.76MM (up 2.43%) and analysts estimated basic earnings per share -$1.26 vs -$0.51. Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.83. The estimated EPS forecast for the next fiscal year is -$2.87 and is expected to report on March 4th, 2020.
To read the full Zymeworks Inc. (ZYME) report, download it here: http://Fundamental-Markets.com/register/?so=ZYME
-----------------------------------------
PRO-DEX, INC. (PDEX) REPORT OVERVIEW
Pro-Dex's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Pro-Dex reported revenue of $6.40MM vs $5.56MM (up 15.09%) and analysts estimated basic earnings per share $0.28 vs $0.08 (up 250.00%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Pro-Dex reported revenue of $22.47MM vs $21.94MM (up 2.38%) and analysts estimated basic earnings per share $0.38 vs $1.26 (down 69.84%). Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019.
To read the full Pro-Dex, Inc. (PDEX) report, download it here: http://Fundamental-Markets.com/register/?so=PDEX
-----------------------------------------
CANTEL MEDICAL CORP. (CMD) REPORT OVERVIEW
Cantel Medical's Recent Financial Performance
For the three months ended January 31st, 2019 vs January 31st, 2018, Cantel Medical reported revenue of $224.54MM vs $213.03MM (up 5.40%) and analysts estimated basic earnings per share $0.45 vs $0.78 (down 42.31%). For the twelve months ended July 31st, 2018 vs July 31st, 2017, Cantel Medical reported revenue of $871.92MM vs $770.16MM (up 13.21%) and analysts estimated basic earnings per share $2.18 vs $1.71 (up 27.49%). Analysts expect earnings to be released on May 30th, 2019. The report will be for the fiscal period ending April 30th, 2019. Reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $2.75 and is expected to report on September 26th, 2019.
To read the full Cantel Medical Corp. (CMD) report, download it here: http://Fundamental-Markets.com/register/?so=CMD
-----------------------------------------
VAALCO ENERGY INC (EGY) REPORT OVERVIEW
Vaalco Energy's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Vaalco Energy reported revenue of $27.61MM vs $17.16MM (up 60.91%) and basic earnings per share $0.17 vs $0.06 (up 183.33%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Vaalco Energy reported revenue of $104.94MM vs $77.03MM (up 36.25%) and analysts estimated basic earnings per share $1.64 vs $0.16 (up 925.00%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019.
To read the full Vaalco Energy Inc (EGY) report, download it here: http://Fundamental-Markets.com/register/?so=EGY
-----------------------------------------
PERION NETWORK LTD (PERI) REPORT OVERVIEW
Perion Network's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Perion Network reported revenue of $71.96MM vs $77.28MM (down 6.88%) and analysts estimated basic earnings per share $0.20 vs -$1.44. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Perion Network reported revenue of $252.85MM vs $273.99MM (down 7.72%) and analysts estimated basic earnings per share $0.31 vs -$2.81. Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.12. The estimated EPS forecast for the next fiscal year is $0.53 and is expected to report on February 12th, 2020.
To read the full Perion Network Ltd (PERI) report, download it here: http://Fundamental-Markets.com/register/?so=PERI
-----------------------------------------
ATLAS FINANCIAL HOLDINGS, INC. (AFH) REPORT OVERVIEW
Atlas Financial's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Atlas Financial reported revenue of $55.77MM vs $57.46MM (down 2.95%) and analysts estimated basic earnings per share $0.47 vs $0.43 (up 9.30%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Atlas Financial reported revenue of $221.98MM vs $177.58MM (up 25.00%) and analysts estimated basic earnings per share -$3.22 vs $0.20. Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.53.
To read the full Atlas Financial Holdings, Inc. (AFH) report, download it here: http://Fundamental-Markets.com/register/?so=AFH
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Arden Dalio, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
